Baichun Yang

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi Effects of a PPARgamma agonist, GI262570, on renal filtration fraction and nitric oxide level in conscious rats
    Baichun Yang
    GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709, USA
    J Cardiovasc Pharmacol 42:436-41. 2003
  2. pmc Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats
    Baichun Yang
    Department of Molecular Pharmacology, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    BMC Pharmacol 4:23. 2004
  3. ncbi PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats
    Baichun Yang
    Department of Molecular Pharmacology, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Biochem Biophys Res Commun 334:176-82. 2005
  4. pmc RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db mice
    Baichun Yang
    Department of Metabolic Molecular Pharmacology, Research and Development, GlaxoSmithKline, Research Triangle Park, USA
    BMC Pharmacol 8:7. 2008
  5. ncbi Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats
    Baichun Yang
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Biochem Biophys Res Commun 341:209-17. 2006
  6. ncbi GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats
    Lihong Chen
    Department of Molecular Pharmacology, GlaxoSmithKline, Inc, Five Moore Drive, Research Triangle Park, NC 27709, USA
    J Pharmacol Exp Ther 312:718-25. 2005

Detail Information

Publications6

  1. ncbi Effects of a PPARgamma agonist, GI262570, on renal filtration fraction and nitric oxide level in conscious rats
    Baichun Yang
    GlaxoSmithKline Research and Development, Research Triangle Park, NC 27709, USA
    J Cardiovasc Pharmacol 42:436-41. 2003
    ....
  2. pmc Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats
    Baichun Yang
    Department of Molecular Pharmacology, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    BMC Pharmacol 4:23. 2004
    ....
  3. ncbi PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats
    Baichun Yang
    Department of Molecular Pharmacology, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Biochem Biophys Res Commun 334:176-82. 2005
    ....
  4. pmc RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db mice
    Baichun Yang
    Department of Metabolic Molecular Pharmacology, Research and Development, GlaxoSmithKline, Research Triangle Park, USA
    BMC Pharmacol 8:7. 2008
    ..We investigated the effects of RU486 on serum cytokines in db/db mice and on lipopolysaccharide (LPS)-induced circulating TNFalpha levels in both normal AKR mice and diet-induced obese (DIO) C57BL/6 mice...
  5. ncbi Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats
    Baichun Yang
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Biochem Biophys Res Commun 341:209-17. 2006
    ..This provides the first evidence for a connection between tissue adiponectin and diet-induced hyperinsulinemia and dyslipidemia...
  6. ncbi GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats
    Lihong Chen
    Department of Molecular Pharmacology, GlaxoSmithKline, Inc, Five Moore Drive, Research Triangle Park, NC 27709, USA
    J Pharmacol Exp Ther 312:718-25. 2005
    ..This may be an important mechanism for PPARgamma agonist-induced fluid retention...